TickerFacts.

OnKure Therapeutics, Inc. (OKUR): Net Income

Annual figures by period end, from SEC filings.

-$59.52M
Year ended 2025-12-31
-$58.70M
Trailing 12 months to 2026-06-30
2020-12-31: -$19.46M2021-12-31: -$39.77M2022-12-31: -$51.95M2023-12-31: -$35.31M2024-12-31: -$52.67M2025-12-31: -$59.52M-$59.52M
2020-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$59.52Mn/m2026-03-12, From 2025-01-01
2024-12-31-$52.67Mn/m2026-03-12, From 2024-01-01
2023-12-31-$35.31Mn/m2025-03-10, From 2023-01-01
2022-12-31-$51.95Mn/m2024-03-28, From 2022-01-01
2021-12-31-$39.77Mn/m2023-03-27, From 2021-01-01
2020-12-31-$19.46Mn/a2022-03-23, From 2020-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
OnKure Therapeutics, Inc. (OKUR)2025-12-31-$59.52Mn/m
Lifevantage Corp (LFVN)2026-06-30$5.07M-48.3%
Rallybio Corp (RLYB)2025-12-31-$8.98Mn/m
AN2 Therapeutics, Inc. (ANTX)2025-12-31-$35.17Mn/m
Q32 Bio Inc. (QTTB)2025-12-31$29.82Mn/m
DiaMedica Therapeutics Inc. (DMAC)2025-12-31-$32.77Mn/m
Pasithea Therapeutics Corp. (KTTA)2025-12-31-$20.43Mn/m
ProPhase Labs, Inc. (PRPH)2025-12-31-$14.74Mn/m
Palvella Therapeutics, Inc. (PVLA)2025-12-31-$41.72Mn/m

Compare OKUR, LFVN, RLYB, ANTX side by side · Screen every company in Pharmaceutical Preparations ↗